Follow-Up Key To Safe Refractive Surgery In Glaucoma

Friday, September 12, 2008

Comments

Ocular Surgery News

Glaucoma patients who undergo LASIK or PRK need careful monitoring of IOP and other parameters to ensure that refractive surgery does not affect the disease, according to two glaucoma specialists.

Full Story

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. None of the above
5. All of the above
Check The Answer

3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Follow-Up Key To Safe Refractive Surgery In Glaucoma

Comments

Related Categories

Refractive Products and Equipment »

Glaucoma Testing Equipment / Glaucoma Products »

Quick Quiz

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?

AdGlare RMR Ad

Featured Products

3nethra classic Ophthalmic Imaging Device

Selecta Trio™ YAG Laser, SLT and Photocoagulation

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us